Kwality Pharmaceuticals Limited (BOM:539997)
755.00
-42.10 (-5.28%)
At close: Apr 24, 2025
Kwality Pharmaceuticals Revenue
Kwality Pharmaceuticals had revenue of 844.07M INR in the quarter ending December 31, 2024, with 8.08% growth. This brings the company's revenue in the last twelve months to 3.46B, up 22.01% year-over-year. In the fiscal year ending March 31, 2024, Kwality Pharmaceuticals had annual revenue of 3.07B with 22.36% growth.
Revenue (ttm)
3.46B
Revenue Growth
+22.01%
P/S Ratio
2.25
Revenue / Employee
4.30M
Employees
806
Market Cap
7.79B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 3.07B | 561.42M | 22.36% |
Mar 31, 2023 | 2.51B | -2.05B | -44.97% |
Mar 31, 2022 | 4.56B | 1.93B | 73.42% |
Mar 31, 2021 | 2.63B | 1.21B | 84.59% |
Mar 31, 2020 | 1.43B | -241.63M | -14.50% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,981.14B |
HDFC Bank | 2,728.47B |
Tata Consultancy Services | 2,553.24B |
Bharti Airtel | 1,627.08B |
ICICI Bank | 2,006.54B |
State Bank of India | 3,409.52B |
Infosys | 1,647.16B |
Bajaj Finance | 358.05B |
Kwality Pharmaceuticals News
- 3 months ago - Kwality Pharmaceuticals receives GMP approval from SFDA for its two manufacturing units in Amritsar - Business Upturn
- 4 months ago - Kwality Pharmaceuticals receives RCGM approval for pre-clinical studies of recombinant Erythropoietin - Business Upturn
- 4 months ago - Kwality Pharmaceuticals gets SAHPRA approval in South Africa for Tamoxifen 20mg tablet - Business Upturn